The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of PDMR Dealing

13 Aug 2020 07:00

RNS Number : 9821V
Mereo BioPharma Group plc
13 August 2020
 

Mereo BioPharma Group plc

 

Notification of PDMR Dealing

 

London and Redwood City, Calif., August 13, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the Company", a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received notification that on August 12, 2020 John Lewicki, Chief Scientific Officer of Mereo, was granted options over 100,000 American Depositary Shares (ADSs) under the Mereo BioPharma Group plc 2019 equity incentive plan for no consideration. The exercise price for these options is USD 2.77 per ADS.

 

Option grants were also made to other Company personnel over a further 100,000 ADSs at the same exercise price.

 

This announcement and the notification below is made in accordance with the EU Market Abuse Regulation. The PDMR disclosure form required under the EU Market Abuse Regulation follows.

 

1

Details of the person discharging managerial responsibilities

a)

Name

John Lewicki

2

Reason for the notification

a)

Position/status

Chief Scientific Officer

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mereo BioPharma Group plc

b)

LEI

213800U8JQHIJOS5AS09

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF £0.003 EACH

b)

Nature of the transaction

GRANT OF AN OPTION (FOR NO CONSIDERATION) UNDER THE MEREO BIOPHARMA GROUP PLC 2019 EQUITY INCENTIVE PLAN. THE EXERCISE PRICE IS US$2.77 PER ADS (FAIR MARKET VALUE AT GRANT)

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

No consideration

100,000

 

 

d)

Aggregated information: volume, Price

e)

Date of the transaction

12-08-2020

f)

Place of the transaction

OUTSIDE OF A TRADING VENUE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGZGMRGZDGGZZ
Date   Source Headline
28th Feb 20073:21 pmRNSHolding(s) in Company
28th Feb 20079:54 amRNSHolding(s) in Company
21st Feb 20074:34 pmRNSHolding(s) in Company
19th Feb 200712:31 pmRNSCircular to Shareholders
16th Feb 20078:32 amRNSHolding(s) in Company
14th Feb 20077:01 amRNSAcquisition
6th Feb 20074:34 pmRNSHolding(s) in Company
9th Jan 20071:00 pmRNSAnnual Information Update
19th Dec 200610:12 amRNSTotal Voting Rights
12th Dec 20065:37 pmRNSResponse to Recent Statements
21st Nov 200611:43 amRNSAmended Block Listing
17th Nov 20064:29 pmRNSAdditional Listing
16th Nov 20063:04 pmRNSDividend Timetable
15th Nov 20067:02 amRNSInterim Results
6th Nov 20069:00 amRNSOzwald Boateng Judgement
1st Nov 20062:47 pmRNSNotice of Results
21st Sep 20062:10 pmRNSHolding(s) in Company
19th Sep 200612:58 pmRNSHolding(s) in Company
14th Sep 200612:46 pmRNSTransaction in Own Shares
12th Sep 200611:53 amRNSResult of AGM
12th Sep 20067:01 amRNSAGM Statement
1st Sep 20065:25 pmRNSDirector/PDMR Shareholding
1st Sep 200611:10 amRNSDirector/PDMR Shareholding
31st Aug 20062:27 pmRNSNotice of AGM
25th Aug 200610:22 amRNSDirector/PDMR Shareholding
21st Aug 20067:01 amRNSDistribution Agreement
21st Aug 20067:00 amRNSAcquisition
19th Jul 20061:48 pmRNSDirector/PDMR Shareholding
28th Jun 20067:02 amRNSFinal Results
1st Jun 20067:01 amRNSJCC Subsidiary Agreement
18th May 200612:00 pmRNSNotice of Results
15th May 200612:45 pmRNSHolding(s) in Company
12th May 200610:16 amRNSHolding(s) in Company
3rd May 20062:37 pmRNSNew Licensing Agreement
28th Apr 20063:55 pmRNSDirector/PDMR Shareholding
4th Apr 200610:38 amRNSHolding(s) in Company
30th Mar 20067:01 amRNSDirector/PDMR Shareholding
29th Mar 20067:01 amRNSDir. Changes/Trading Update
22nd Mar 20064:41 pmRNSHolding(s) in Company
14th Mar 20069:02 amRNSDirector/PDMR Shareholding
10th Mar 20065:27 pmRNSHolding(s) in Company
8th Mar 20061:23 pmRNSHolding(s) in Company
8th Mar 20067:02 amRNSDirectors' Shareholdings
7th Mar 20067:04 amRNSAcquisition
2nd Mar 20064:53 pmRNSBlocklisting Application
7th Dec 20057:02 amRNSMarchpole Update
1st Dec 200512:03 pmRNSHolding(s) in Company
16th Nov 20054:23 pmRNSDividend Timetable
16th Nov 20057:02 amRNSDirectorate Change
16th Nov 20057:02 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.